Koenig Sheldon L.
President and CEO
Koenig Sheldon L. has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 13, 2026.
On the most recent filing, Koenig Sheldon L. is listed as President and CEO at Esperion Therapeutics, Inc. Inside the rolling window, Koenig Sheldon L. reported no open-market purchases and 4 open-market sales totaling $495K in ESPR. The largest disclosed transaction in the window is a sale of 48,244 ESPR shares on Dec 17, 2025, worth $177K.
Companies traded
Other insiders at ESPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$495K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Koenig Sheldon L. made?
Koenig Sheldon L. has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Koenig Sheldon L. trade?
Koenig Sheldon L. has filed SEC Form 4 disclosures for 1 company, including ESPR.
When was Koenig Sheldon L.'s most recent SEC Form 4 filing?
Koenig Sheldon L.'s most recent SEC Form 4 filing on Tracefour is dated Jul 13, 2026.
What is Koenig Sheldon L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Koenig Sheldon L. is listed as President and CEO.
What is Koenig Sheldon L.'s total buy and sell value in the current window?
Inside the rolling retention window, Koenig Sheldon L. bought $0 and sold $495K based on SEC Form 4 filings.
What was Koenig Sheldon L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 48,244 ESPR shares on 2025-12-17, worth $177K, per SEC Form 4 filings.